Showing results (41-50 of 4,276) with videos related to
Sort By:
Pageof 428
Therapeutics and Clinical Risk Management|August 2, 2017
Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosisCristina Guarnera, Placido Bramanti, Emanuela MazzonBiophysical Journal|September 16, 2009
How does a simplified-sequence protein fold?Enrico Guarnera, Riccardo Pellarin, Amedeo CaflischTomography (Ann Arbor, Mich.)|September 26, 2021
Idiopathic Interstitial Pneumonias and COVID-19 Pneumonia: Review of the Main Radiological Features and Differential DiagnosisAlessia Guarnera, Elena Santini, Pierfrancesco PoddaTomography (Ann Arbor, Mich.)|February 24, 2022
COVID-19 Pneumonia and Lung Cancer: A Challenge for the RadiologistReview of the Main Radiological Features, Differential Diagnosis and Overlapping PathologiesAlessia Guarnera, Elena Santini, Pierfrancesco PoddaJournal of Molecular Biology|November 22, 2007
Pathways and intermediates of amyloid fibril formationRiccardo Pellarin, Enrico Guarnera, Amedeo CaflischActa Paediatrica (Oslo, Norway : 1992)|January 29, 2013
Rotation and generation of mental imagery in children with specific language impairmentMaria Guarnera, Elena Commodari, Cristina PelusoDrug Design, Development and Therapy|August 18, 2017
Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosisCristina Guarnera, Placido Bramanti, Emanuela MazzonRevue D'Epidemiologie Et De Sante Publique|January 1, 1994
[Tests and estimates of the association in case-control studies: analysis of 2 x 2 and k x 2 x 2 tables]M ColonnaImmunity|July 17, 2009
Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunityMarco ColonnaRevue D'Epidemiologie Et De Sante Publique|March 18, 2011
[Descriptive analysis of trend of epidemiological observational data using JoinPoint: a user-friendly tool, seemingly]M ColonnaPageof 428